Effects of ibandronate-hydroxyapatite on resorptive activity of osteoclasts

Archives of Medical Science

Volumn 7, Issue 1, 2011, Pages 53-60

  Zhang, Xiaohui ^a   Hu, Jing ^a   Li, Yunfeng ^a   Yin, Guozhu ^a   Luo, En ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Biomaterial; Bisphosphonate; Hydroxyapatite; Osteoclast

Indexed keywords

HYDROXYAPATITE; IBANDRONIC ACID;

ANIMAL CELL; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PHASE CONTRAST MICROSCOPY; RAT; TRANSMISSION ELECTRON MICROSCOPY;

EID: 79952531908     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.20604     Document Type: Article

References (23)

1. He G, Hu J, Wei SC, Li JH, Liang XH, Luo E. Surface modification of titanium by nano-TiO2/HA bioceramic coating. Applied Surface Science 2008; 255: 442-5.
2. Makras P, Hamdy NAT, Zwinderman AH. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis. Bone 2009; 44: 766-71.
3. Cukrowski I, Popovic L, Barnard W, Paul SO, van Rooyen PH, Liles DC. Modeling and spectroscopic studies of bisphosphonate-bone interactions. The Raman, NMR and crystallographic investigations of Ca-HEDP complexes. Bone 2007; 41: 668-78.
4. Rogers MJ, Gordon S, Benford HL, et al. Cellular and molecular mechanisms of action of bisphosphonates. Cancer 2000; 88: 2961-78. (Pubitemid 30413179)
5. Kajiwara H, Yamaza T, Yoshinari M, et al. The bisphosphonate pamidronate on the surface of titanium stimulates bone formation around tibial implants in rats. Biomaterials 2005; 26: 581-7. (Pubitemid 38988300)
6. Luo E, Wei SC, He G, Xiao L, Zhao Q. The bisphosphonate clodronate modifying hydroxyapatite bioceramics for bone scaffold. J. Wuhan Univ Technol 2005; 20: 98-101.
7. Luo E, Liu X, Wei SC, Cai XX, Hu J. Osteoblast adhesion to clodronate-hydroxyapatite composite. Applied Surface Science 2008; 255: 308-11.
8. Luo E, Cui J, Gao Y, Lin YF, Zhu SS, Hu J. Effect of pamidronate on protein adsorption and osteoblast adhesion to hydroxyapatite bioceramics scaffold. Key Engineering Materials 2007; 330: 885-8. (Pubitemid 46120913)
9. Xie Z, Jiang Y, Zhang DQ. Simple analysis of four bisphosphonates simultaneously by reverse phase liquid chromatography using n-amylamine as volatile ion-pairing agent. J Chromatogr A 2006; 1104: 173-8. (Pubitemid 43099889)
10. Chambers TJ, Magnus CJ. Calcitonin alters behaviour of isolated osteoclasts. J Pathol 1982; 136: 27-39.
11. Swain VM, Xue J. State of the Art of Micro-CT Applications in Dental Research. International Journal of Oral Science 2009; 4: 177-88.
12. Garnero P, Schott AM, Prockop D, Chevrel G. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: Associations with collagen gene mutations. Bone 2009; 44: 461-6.
13. Rogers MJ, Watts DJ, Russell RG. Overview of bisphosphonates. Cancer 1997; 80: 1652-60. (Pubitemid 27444037)
14. Russell RGG, Rogers MJ. Bisphosphonates: from the laboratory to the clinic and back again. Bone 1999; 25: 97-106. (Pubitemid 29322070)
15. Fleisch H. Bisphosphonates: mechanisms of action. Endocr Rev 1998; 19: 80-100. (Pubitemid 29122075)
16. Frith JC, Monkkonen J, Blackburn GM, Russell RG, Rogers MJ. Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5′-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res 1997; 12: 1358-67. (Pubitemid 27375378)
17. Riihonen R, Supuran CT, Parkkila S, Pastorekova S, Väänä nen HK, Laitala-Leinonen T. Membrane-bound carbonic anhydrases in osteoclasts. Bone 2007; 40: 1021-31. (Pubitemid 46386547)
18. David P, Nguyen H, Barbier A, Baron R. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase. J Bone Miner Res 1996; 11: 1498-507. (Pubitemid 26331005)
19. Zimolo Z, Wesolowski G, Rodan GA. Acid extrusion is induced by osteoclast attachment to bone. Inhibition by alendronate and calcitonin. J Clin Invest 1995; 96: 2277-83.
20. Yoshinari M, Oda Y, Ueki H, Yokose S. Immobilization of bisphosphonates on surface modified titanium. Biomaterials 2001; 22: 709-15. (Pubitemid 32112295)
21. Epker BN, Frost HM. Correlation of bone resorption and formation with the physical behavior of loaded bone. J Dent Res 1965; 44: 33-41.
22. Wang ML, Sharkey PF, Tuan RS. Particle bioreactivity and wear-mediated osteolysis. J Arthroplasty 2004; 19: 1028-38.
23. Kandil ME, Mourad A, El Hamshary A. Evaluation of bone mineral density and bone turnover markers in Egyptian children with juvenile rheumatoid arthritis. Arch Med Sci 2009; 5: 434-42.